Eli Lilly Reduces Cash Prices of Zepbound Weight Loss Drug Vials on Direct-to-Consumer Platform
Eli Lilly Reduces Cash Prices of Zepbound Weight Loss Drug Vials on Direct-to-Consumer Platform In a significant development within the pharmaceutical and weight management sectors, Eli Lilly has announced a reduction in the cash prices of its weight loss drug, Zepbound, when purchased directly through…
- Coast Guard Tracks Down Runaway Oil Tanker Linked to Iran and Venezuela

- Trump Rings in Christmas Day with Flurry of Posts Denouncing Perceived Foes and Casting Doubt on the 2020 Election

- Saudi Arabia Urges Yemen’s Separatists to Withdraw from Two Governorates Amid Coalition Strains

- House and Senate Committees Launch Investigations into Reported Second Strike on Alleged Drug Boat

- One Year On From Martial Law Crisis, South Korea Celebrates Its Democracy’s Resilience
